Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Bioequivalence Study on Two Lisinopril Tablets 20mg Formulations

NCT03599466 is registered in ClinicalTrials.gov with Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited as lead sponsor.

NCT NCT03599466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03599466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Bioequivalence Study on Two Lisinopril Tablets 20mg Formulations
Lead sponsor
Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited
Phase
Phase 1
Overall status
Unknown status
Start date
October 31, 2019
Completion date
April 30, 2020
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy